Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. financial statements

Jasper Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 75.8M10-K
Cash and equivalentsUSD 28.69M10-Q
Total debtUSD 1.24MEODHD

Jasper Therapeutics, Inc. financials on 6ix · Jasper Therapeutics, Inc. on 6ix